| 2019 | | Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy | 남동호, 박해심, 신유섭, 예영민, 이소희 |
| 2010 | | Immunoglobulin G subclass deficiency is the major phenotype of primary immunodeficiency in a Korean adult cohort. | 김정은, 김주희, 남동호, 박해심, 예영민, 최길순 |
| 2014 | | Immunologic evaluation of immediate hypersensitivity to cefaclor | 김승현, 박해심, 예영민, 유혜수 |
| 2021 | | Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial | 신유섭 |
| 2014 | | Letter to the editor. Two major phenotypes of sulfite hypersensitivity: asthma and urticaria. | 박해심, 반가영, 예영민, 유혜수 |
| 2018 | | Proper Cut-off Levels of Serum Specific IgE to Cefaclor for Patients with Cefaclor Allergy | 박해심, 신유섭, 예영민, 이소희, 이영수 |
| 2019 | | Real-life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred-dose inhalers in patients with asthma treated with ICS/LABA | 박해심, 윤덕용 |
| 2024 | | Real-World Effectiveness of Statin Therapy in Adult Asthma | 박래웅, 박해심, 양형모, 이영수, 장재혁 |
| 2024 | | Real-world treatment trajectories of adults with newly diagnosed asthma or COPD | 박래웅, 박해심, 이영수 |
| 2003 | | Serum cytokine profiles in patients with adult onset Still's disease. | 남동호, 박해심, 서유진, 서창희, 최정희 |
| 2017 | | Subcutaneous Immunotherapy for Allergic Asthma in a Single Center of Korea: Efficacy, Safety, and Clinical Response Predictors | 남동호, 박해심, 반가영, 신유섭, 예영민, 이지호, 정창규 |
| 2022 | | The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea | 박해심, 예영민 |
| 2023 | | Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study | 예영민, 이영수 |
| 2019 | | Variation of clinical manifestations according to culprit drugs in DRESS syndrome | 예영민 |
